Indole compounds useful as serotonin selective agents

Details Indole compounds useful as serotonin selective agents Indole compounds useful as serotonin selective agents

2005-09-27

2010-02-02

Anderson, Rebecca L (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S414000, C548S491000

Reexamination Certificate

active

07655691

ABSTRACT:
Novel indole compounds are disclosed. Also disclosed are methods for using the compounds to treat human and animal disease, pharmaceutical compositions of the compounds, and kits including the compounds.

REFERENCES:
patent: 3075992 (1963-01-01), Hofmann et. al.
patent: 9005721 (1990-05-01), None
patent: 0012482 (2000-03-01), None
Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 2050-2057.
Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 1992-1996.
FDA mulls drug to slow late-stage Alzheimer's [online],[retrieved on Sep. 23, 2003].Retrieved from the Internet, URL; http://www.cnn.com/2003/Health/conditions/09/24/alzheimers.drug.ap/indexhtml>.
Autism[online],[retrieved on Dec. 5, 2006]. Retrieved from the Internet, URL; http://en.wikipedia.org/wiki/Autism>.
Whitaker-Azmitia, P. Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? Int. J. Devl Neuroscience (2005), 23, 75-83.
Acral Lick Dermatitis (lick granuloma)[online],[retrieved on Aug. 29, 2007]. Retrieved from the Internet, URL; http://www.animalhealthcare.com/handouts/dogs/acrall1.htm>.
Vippagunta, et al. Advanced Drug Delivery Reveiws 48 (2001) pp. 3-26.
Audia et al. “Potent, Selective Tetrahydro-β-carboline Antagonists of the Serotonin 2B (5HT2B) Contractile Receptor in the Rat Stomach Fundus,” J. Med. Chem. (1996), vol. 39, pp. 2773-2780.
Bickerdike, et al. “5-HT2C receptor modulation and the treatment of obesity,” Diabetes, Obesity and Metabolism, (1999), vol. 1, pp. 207-214.
Blakeslee “Scientists Test Hallucinogens for Mental Ills,” New York Times (Mar. 31, 2001), (4 pages).
Blair, et al. “Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines” J. Med. Chem. (2000), vol. 43, pp. 4701-4710.
Bos, et al. “Novel Agonists of 5-HT2CReceptors. Synthesis and Biological Evaluation of Substituted 2-(Indol-1-yl)-1-methylethylamines and 2-(Indeno[1,2-b]pyrrol-1-y1)-1-methylethylamines. Improved Therapeutics for Obsessive Compulsive Disorder,” J. Med. Chem. (1997), vol. 40, pp. 2762-2769.
Brodey, et al, abstract of “An electrographic study of psilocin and 4-methyl-α'-methyl-tryptamine,” J. of Pharm. & Exp. Ther. (1963), vol. 140, pp. 8-18.
Cliffe, et al. “Approaches to 5-HT2CReceptor Agonists: Activity of Saturated Cycloalkyl-fused [b]Indole and [b]Indole and [b]Indoline Isotryptamines”Excellence in Neuroscience and CNS Medicine, 224thACS National Meeting, (Aug. 18-22, 2002), Boston, (6 pages).
Delgado, et al. “Hallucinogens, Serotonin, and Obsessive-Compulsive Disorder,” J. Psychoactive Drugs (Oct.-Dec. 1998), vol. 30(4), pp. 359-366.
Fitzgerald, et al. “5-HT2C Receptor Modulators: Progress in Development of New CNS Medicines,” Annual Reports in Medicinal Chemistry (2002), vol. 37, pp. 21-30.
Fitzgerald, et al. “Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine,” Molecular Pharmacology (2000), vol. 57, pp. 75-81.
Glennon, et al. “Influence of Amine Substituents of 5-HT2A Versus 5-HT2C Binding of Phenylalkyl-and Indolylalkylamines,” J. Med. Chem. (1994), vol. 37, pp. 1929-1935.
Goodman, W. K. “Obsessive-Compulsive Disorder: Diagnosis and Treatment” J. Clin. Psychiatry (1999), vol. 60(Suppl. 18), pp. 27-32.
Jacob, et al. “Structure-Activity Relationships of the Classic Hallucinogens and Their Analogs”NIDA Research Monograph146 (Hallucinogens, an Update), Eds. Lin, G. C. and Glennon, R. A., (1994), pp. 74-91.
Martin, et al. “5-HT2C Receptor Agonists: Pharmacological Characteristics and Therapeutics Potential,” Journal of Pharmacology and Experimental Therapeutics, (1998), vol. 285, pp. 913-924.
Moreno, et al. “Hallucinogen-Induced Relief of Obsessions and Compulsions,” Am. J. Psychiatry (1997), vol. 154, pp. 1037-1038.
Perrine, D.M. “Hallucinogens and Obsessive-Compulsive Disorder,” Am. J. Psychiatry (1999), vol. 156, pp. 1123.
Roth, et al. “Insights into the structure and function of 5-HT2 family serotonin receptors reveal novel strategies for therapeutic target development,” Expert. Opin. Ther. Targets (2001), vol. 5(6), pp. 685-695.
Rothman, et al. “Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications,” Circulation (2000), vol. 102, pp. 2836-2841.
Smith, et al. “Discovery and SAR of new benzazepines as potent and selective 5-HT2C receptor agonists for the treatment of obesity,” Bioorganic & Medicinal Chemistry Letters (2005), vol. 15, pp. 1467-1470.
Tecott, et al. “Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors,” Nature (Apr. 6, 1995), vol. 374, pp. 542-546.
Ückert, et al. “Current and Future Trends in the Oral Pharmacotherapy of Male Erectile Dysfunction,” Expert Opin. lnvestig. Drugs (2003), vol. 12(9), pp. 1521-1533.
Welmaker, et al. “Synthesis and 5-Hydroxytryptamine (5-HT) Activity of 2,3,4,4a-Tetrahydro-1H-pyrazino[1,2-α]quinoxalin-5-(6H)ones and 2,3,4a,5,6-Hexandro-1H-pyrazino[1,2-α]quinoxalines,” Bioorganic & Medicinal Chemistry Letters (2000), vol. 10, pp. 1991-1994.
International Search Report and Written Opinion for International Application No. PCT/US05/34413 (11 pages).
Cerletti et al., Advances in Pharmacology (New York) (1968), 6 (Pt. B), 233-46.
International Search Report from corresponding international patent application No. PCT/US2005/034413, dated May 8, 2009.
Blair et al, “Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines,” Journal of Medicinal Chemistry (2000) p. 4701-4710 August.

Affiliated with

Also associated with

Rating

Indole compounds useful as serotonin selective agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole compounds useful as serotonin selective agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole compounds useful as serotonin selective agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4162665